Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-02-06
DOI
https://doi.org/10.1186/s13063-025-08750-9
Citations
1
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
1.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study

Jo Kitawaki, Fuminori Taniguchi, Tasuku Harada, Yutaka Osuga et al.
1 citations
Trials
Endometriosis Research and Treatment
1.70
article

Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study

Jo Kitawaki, Fuminori Taniguchi, Tasuku Harada, Yutaka Osuga, Motoko Fukui
article en
1 citations

Abstract

No abstract available for this paper.
TrialsVol. 26(1)
Kyoto Prefectural University of Medicine (JP), ASKA Pharmaceutical (Japan) (JP), Tottori University (JP), The University of Tokyo (JP)
Zero hunger
Openalex Percentile: Top 20%
Endometriosis Research and Treatment
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.